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FIGURE 2. Transthoracic echocardiogram pretransplant (A) and posttransplant (B), showing changes in right and left ventricular diameters. LA, Left
atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
Brief Clinical Reportsventricular dysfunction seen in patients undergoing LTx
for pulmonary hypertension4 were associated with the
mechanism of regurgitation in this case. The influence of
the tricuspid annuloplasty remains unclear, requiring fur-
ther analysis.CONCLUSIONS
We report this unusual case because it demonstrates
a rare mechanism of MR after LTx requiring surgical repair.
Close observation of left ventricular and mitral annular
anatomy is necessary after LTx in patients with severe pul-
monary hypertension. Inverse remodeling of the left-sidedFrom the Department of Thoracic and Cardiovascular Surgery, Heart and Vascular In-
stitute, Cleveland Clinic, Cleveland, Ohio.
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The Journal of Thoracic and Cstructures could be associated with clinically relevant,
new-onset MR.
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1999;18:304-9.Third-time lung transplantation in a patient with cystic fibrosisNakul Vakil, MD, David P. Mason, MD, James J. Yun, MD, PhD, Sudish C. Murthy, MD, PhD,
Marie M. Budev, DO, and Gosta B. Pettersson, MD, PhD, Cleveland, OhioRespiratory failure is the leading cause of death in patients
with cystic fibrosis (CF), and lung transplantation (LTx) is
the only treatment option for patients with end-stage dis-
ease. Unfortunately, the long-term success of LTx is limited
by the development of bronchiolitis obliterans syndrome
(BOS), and retransplantation (re-LTx) for these patients is
infrequent and controversial.1-4 Concerns include (1) the
technical difficulty of re-LTx; (2) immunologic barriers
imparting worse survival in patients whose first graftsardiovascular Surgery c Volume 141, Number 1 e3
FIGURE 1. Chest radiograph 24 months after third-time DLTx.
Brief Clinical Reportshave already failed; and (3) the appropriateness of reallo-
cating them a scare resource. Because patients with CF
tend to be the youngest patients undergoing LTx, the
need for re-LTx and even multiple re-LTxs may become in-
creasingly common. Third-time LTx has been reported only
once and never in a patient with CF.5 This case highlights
the feasibility and good mid-term survival of third-time
LTx in a patient with CF.
CLINICAL SUMMARY
A 25-year-old man with a history of CF and insulin-
dependent diabetes mellitus presented to the Cleveland
Clinic with BOS after his second double lung transplant
(DLTx) at another institution. His medical history included
a diagnosis of CF as an infant with the eventual development
of respiratory failure necessitating DLTx with atrial septal
defect repair at age 17 years.He didwell for 4 years, at which
point he became dyspneic. He was treated for presumed re-
jection with pulse steroids and OKT3 but eventually had
worsening respiratory failure secondary to BOS. He under-
went re-DLTx6 years after his initialDLTx and had a smooth
postoperative course. However, after only 1 year, he noted
worsening dyspnea. Despite immunologic interventions,
including antithymocyte globulin, photopheresis, metho-
trexate, and pulse steroids, severe BOS again developed.
He had no ongoing posttransplant infectious complications
or resistant organisms. He presented to the Cleveland Clinic
for consideration of third-time LTx, 8 years after his first
LTx and 2 years after his second LTx.
The patient was ambulatory, required 2 liters continuous
oxygen, and had a forced expiratory volume at 1 second of
12% of predicted, a body mass index of 14.7 kg/m2, and
normal renal function. His panel reactive antibody level
was 15% with specificity only to human leukocyte antigen
locus DQ4. His medications included prednisone 10 mg per
day, tacrolimus, mycophenolate mofetil, and azithromycin.
Given his preserved fitness despite severe single-system
organ dysfunction, young age, and relatively long period
of survival after his transplants, the patient was listed for
third-time DLTx. His lung allocation score was 36.4.
An appropriate donor became available after 1month, and
the patient underwent third-time DLTx. At surgery, the chest
was entered through the previous transverse sternothoracot-
omy. There were dense pleural adhesions bilaterally that
were lysed using electrocautery off of cardiopulmonary by-
pass. However, after complete mobilization of the lungs and
intrapericardial dissection, severe hypercapnia and accom-
panying hemodynamic instability necessitated institution
of right atrial to ascending aortic cardiopulmonary bypass.
Sequential DLTx was then performed with only slight mod-
ification from standard implantation techniques. Recipient
pneumonectomies were carried out, and the airways were
trimmed back proximal to the old anastomoses. However,
the pulmonary artery and left atrium were transected distale4 The Journal of Thoracic and Cardiovascular Surgeto the previous vascular anastomoses to allow further sewing
length and then easily approximated to the donor tissue. Total
ischemic time was 5 hours and 40 minutes, and total cardio-
pulmonary bypass time was 3 hours and 17 minutes. The pa-
thology of the explanted lungs showed acute and chronic
bronchiolitis with bronchiectasis.
The patient’s postoperative course was complicated by
reoperation for hemothorax evacuation on postoperative
day 2 and closure of a small parenchymal airleak on postop-
erative day 11. The patient otherwise did well and was dis-
charged on postoperative day 23. At 24 months after his
third-time DLTx, he had a clear radiograph with slight left
hemidiaphragm elevation (Figure 1), no clinical rejection
episodes with all transbronchial biopsies graded A0B0, no
dyspnea, and a forced expiratory volume at 1 second that
was stable at 53% of predicted.DISCUSSION
Although third-time LTx is rare, even second-time trans-
plantation is infrequent and controversial.6 Because of the
infrequency of re-LTx, there are few series examining out-
comes. The largest study, by Kawut and colleagues,4 evalu-
ated the entire US experience of re-LTx. Although survival
was worse after re-LTx, it was improved in the most modern
retransplant cohort and only slightly worse than primary
transplantation. Risk factors for mortality included re-LTx
within 30 days of primary LTx and being on mechanicalry c January 2011
Brief Clinical Reportsventilation at the time of re-LTx. Although our patient had
severe respiratory compromise, he had preserved muscle
mass, was several years removed from his most recent trans-
plant, and had no other organ system failure such as renal
dysfunction.
BOS remains the main cause of chronic graft dysfunction
after LTx, and retransplantation is the only definitive treat-
ment.6 Freedom from BOS in patients with CF receiving
LTx is disappointingly low, only 38% at 10 years.7 Because
of their young age at initial transplantation, an increasing
number of patients with CF may eventually require re-LTx
and perhaps even multiple transplants.8 This case report is
the first to describe third-time LTx in this patient population.
Our initial concern when considering this patient for
third-time surgery was that pleural adhesions that often ac-
company suppurative lung disease might prove problematic
in the reoperative setting. Although pleural adhesions were
noted to be significant and likely contributed to the compli-
cation of postoperative hemothorax, they were not prohib-
itive. An additional concern was that the patient might have
early BOS given his shortened BOS-free survival after the
second LTx when compared with the first. However, at 24
months since his transplant, the patient has had no evidence
of acute or chronic rejection. In the only other report of
a patient undergoing third-time LTx, in Australia, a Maas-
tricht category IV donor after cardiac death was used be-
cause of ethical concerns about appropriate organ
allocation.5 The authors suggest that this ‘‘extended crite-
ria’’ donor otherwise would not have been used. The lungFrom the Department of Cardio-Thoracic Surgery, Division of Heart and Lungs, Uni-
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such an approach in the United States, and the ethical
debate regarding organ allocation for retransplantation re-
mains unresolved.CONCLUSIONS
Clearly, this is a single patient outcome, and this report
should not be considered an endorsement of broad adoption
of third-time LTx. However, this case demonstrates the fea-
sibility and good mid-term survival of a third-time LTx with
no obvious early immune-mediated dysfunction. Larger se-
ries of third-time transplant recipients will be necessary to
determine the appropriateness of this aggressive therapy.References
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Semin Respir Crit Care Med. 2009;30:559-68.Acute limb ischemia after internal thoracic artery harvesting:
A case reportLinda M. de Heer, MD, Marc P. Buijsrogge, MD, and Jaap R. Lahpor, MD, Utrecht, The NetherlandsThe use of the left internal thoracic artery and/or right inter-
nal thoracic artery for coronary revascularization is prefera-
ble to ensure prolonged graft patency.1We report the case of
a 69-year-old man who underwent coronary artery bypassgrafting in which harvesting of the left internal thoracic ar-
tery resulted in critical ischemia of the left limb, leaving up-
per leg amputation as the only option. This patient had
a long-standing occlusion of the distal abdominal aorta
and the left and right common iliac arteries with an open ex-
ternal iliac and left common femoral artery and completely
relied on the internal thoracic arteries as the major source of
blood supply to the legs. A recommendation for themanage-
ment of patients with indications for coronary artery bypass
grafting and aorto-iliac occlusive disease is given.
CLINICAL SUMMARY
A 69-year-old man was admitted to the hospital because
of chronic stable angina pectoris. On physical examination,ardiovascular Surgery c Volume 141, Number 1 e5
